CC BY-NC-ND 4.0 · Journal of Health and Allied Sciences NU 2012; 02(04): 22-27
DOI: 10.1055/s-0040-1703607
Original Article

PREVALENCE OF METABOLIC SYNDROME AND COMORBID CONDITIONS IN INMATES OF OLD AGE HOMES

Sathyanarayana Rao K. N.
1   Professor, Department of Pharmacology, K.S. Hegde Medical Academy, Nitte University, Mangalore, Deralakatte, Mangalore - 575018, Karnataka, India
,
Subbalakshmi N. K.
2   Associate Professor, Department of Physiology, Kasturba Medical College, Manipal University, Light House Hill Road, Mangalore - 575 001, Karnataka, India
› Author Affiliations

Abstract

Introduction: It is imperative that efforts are to be made to recognize individuals with metabolic syndrome from different sets of population so that they may be identified for intensive risk factor management to reduce cardiovascular risk. We evaluated the incidence and associated factors of metabolic syndrome in inmates of old age homes.

Methods: This study involved 189 subjects aged between 55-75 years of either sex housed in old age homes. In every subject waist circumference, blood pressure, fasting blood sugar and plasma lipids were measured. Ongoing treatments were taken into account. Patients with metabolic syndrome were identified using IDF-2005 definition. Data analysis was done by Chi -square test. p value less than 0.05 was taken as significant.

Result: Metabolic syndrome was found in 57.67% of study subjects. Prevalence of metabolic syndrome was higher in 55 - 60 years age group (x2 =17.06, p < 0.01) and in females (x2 = 4.33, p < 0.05). Disease load of dyslipidemia, diabetes mellitus and hypertension was higher in metabolic syndrome group compared to non-metabolic syndrome group (x2 = 11.40, p<0.001; x2 = 47.90, p<0.0001; x2 = 4.72, p<0.05 respectively). In patients receiving treatment for diabetes and hypertension, frequency of subjects with hyperglycemia and high blood pressure was higher in metabolic syndrome group compared to non-metabolic syndrome group (x2 = 10.69, p<0.01; x2 = 4.46, p<0.05 respectively).

Conclusion: In this population it is found that, 55-60 years age group and females are at greater risk for metabolic syndrome. Subjects with metabolic syndrome are resistant to anti-diabetic and antihypertensive treatment.



Publication History

Article published online:
29 April 2020

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • References

  • 1 Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37:1595–607.
  • 2 Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 2004; 24:13–8.
  • 3 Richard Kahn, John Buse, Ele Ferrannini, Michael Stern. The Metabolic Syndrome: Time for a Critical Appraisal Joint Statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28:2289-304.
  • 4 Cameron AJ, Shaw JE, Zimmet PZ. The Metabolic Syndrome: Prevalence in Worldwide Populations. Endocrinol Metab Clin North Am 2004; 33:351–76.
  • 5 Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care 2005; 28:2745-9.
  • 6 Theodoros Loizou, Stavros Pouloukas, Charalambos Tountas, Anastasia Thanopoulou, Vasilios Karamanos, An Epidemiologic Study on the Prevalence of Diabetes, Glucose Intolerance, and Metabolic Syndrome in the Adult Population of the Republic of Cyprus. Diabetes Care 2006; 29:1714-5.
  • 7 Park HS, Lee SY, Han JH, Kim DJ. Prevalence of the Metabolic Syndrome Among Korean Adults According to the Criteria of the International Diabetes Federation Diabetes Care 2006; 29:933-4.
  • 8 Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005; 112:3066-72.
  • 9 McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, Ballantyne CM, Heiss G: The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care 2005; 28:385–90.
  • 10 Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB, Wilson PW: Creactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 2004; 110:380-5.
  • 11 Gerard T Chew, Seng Khee Gan and Gerald F Watts. Revisiting the metabolic syndrome. Medical Journal of Australia 2006; 185:445-9.
  • 12 Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365:1415-28.
  • 13 Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15:539–53.
  • 14 Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486–97.
  • 15 Adams RJ, Appleton S, Wilson DH, et al. Population comparison of two clinical approaches to the metabolic syndrome: implications of the new International Diabetes Federation consensus definition. Diabetes Care 2005; 28:2777-79.
  • 16 Peter Libby. The pathogenesis, prevention and treatment of atherosclerosis. In: Fauci, Braunwald, kasper, Hauser, Longo, Janesen, Loscalzo (eds). Harrison's principles of internal medicine. McGraw-Hill However based on our study findings it could be concluded that prevalence of metabolic syndrome is higher in age group 55-60 years and in females. Disease load of hypertension and diabetes mellitus is found to be higher in subjects with metabolic syndrome. Hyperglycemia and high blood pressure persists despite receiving blood sugar lowering agents and antihypertensive drugs. Conflict of Interest Statement: There are no conflicts of interest Medical. 2008; ch. 235.
  • 17 Gogia A, Agarwal PK. Metabolic syndrome. Indian Journal of Medical Sciences 2006; 60:72-81.
  • 18 Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. Metabolic syndrome in urban Asian Indian adults-a population study using modified ATP III criteria. Diabetes Res Clin Pract 2003; 60:199-204.
  • 19 Gupta A, Gupta R, Sarna M, Rastogi S, Gupta VP, Kothari K. Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population. Diab Res Clin Pract 2003; 61:69-76.
  • 20 Hamid N, Jilliani G, Parveen N, I Haq IU, Arif S, Hussain H. Metabolic syndrome and its relationship with associated risk factors. J. Med. Sci. 2010; 18:186-90.
  • 21 Ravikiran M, Bhansali A, Ravikumar P, Bhansali S, Dutta P, Thakur JS, Sachdeva N, Bhadada S, Walia R. Prevalence and risk factors of metabolic syndrome among Asian Indians: a community survey. Diabetes Res Clin Pract. 2010; 89:181-8.
  • 22 Gupta R, Deedwania PC, Gupta A, Rastogi S, Panwar RB, Kothari K: Prevalence of metabolic syndrome in an Indian urban population. Int J Cardiol 2004; 97:257-61.
  • 23 Chow CK, Naidu S, Raju K, Raju R, Joshi R, Sullivan D, Celermajer DS, Neal BC. Significant lipid, adiposity and metabolic abnormalities amongst 4535 Indians from a developing region of rural Andhra Pradesh. Atherosclerosis 2008; 196:943–52.
  • 24 Apurva Sawant, Ranjit Mankeshwar, Swarup Shah, Rani Raghavan, Gargi Dhongde, Himanshu Raje, Shoba D'souza, Aarti Subramanium, Pradnya Dhairyawan, Seema Todur, and Tester F. Ashavaid. Prevalence of Metabolic Syndrome in Urban India. Cholesterol 2011; 2011:1-7.
  • 25 Ford ES, Giles WH, Dietz WH. Prevalence of the Metabolic Syndrome Among US Adults Findings From the Third National Health and Nutrition Examination Survey. JAMA 2002; 287:356-9.
  • 26 Ogbera AO, Prevalence and gender distribution of the metabolic syndrome. Diabetology & Metabolic Syndrome 2010, 2:1.
  • 27 Mabry RM Reeves MM, Eakin EG, Owen N. Gender differences in prevalence of the metabolic syndrome in Gulf Cooperation Council Countries: a systematic review. Diabet Med. 2010; 27:593-7.
  • 28 Hwang LC, Bai CH, Chen CJ, Chien KL. Gender difference on the development of metabolic syndrome: a population based study in Taiwan. Eur J Epidemiol 2007; 22:899-906.
  • 29 Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K; DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med. 2004; 164:1066-76.
  • 30 Franco OH, Massaro JM, Civil J, Cobain MR, O'Malley B, D'Agostine RB Sr. Trajectories of entering the metabolic syndrome: the Framingham Heart Study. Circulation. 2009; 120:1943-50.
  • 31 Kjeldsen SE, Naditch-Brule L, Perlini S, Zidek W, Farsang C. Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey. J Hypertens. 2008; 26:2064-70.
  • 32 Zidek W, Naditch-Brûlé L, Perlini S, Farsang C, Kjeldsen SE. Blood pressure control and components of the metabolic syndrome: the GOOD survey. Cardiovasc Diabetol. 2009; 8:51.
  • 33 Worawongprapa O. Glycemic control in diabetes with metabolic syndrome in community hospital. J Med Assoc Thai. 2008; 91:641-7.